Article

The occurrence of atopic dermatitis in North Europe: An international questionnaire study

Kristianstad University, Kristianstad, Skåne, Sweden
Journal of the American Academy of Dermatology (Impact Factor: 5). 06/1996; 34(5 Pt 1):760-4. DOI: 10.1016/S0190-9622(96)90009-2
Source: PubMed

ABSTRACT Atopic dermatitis is a common multifactorial disease that seems to be increasing in frequency.
Our purpose was to determine the increased prevalence of atopic dermatitis in North Europe.
Approximately 3000 7-year-old children in Denmark, Germany, and Sweden were enrolled in a cross-sectional questionnaire study that was conducted in the autumn of 1992 with common protocols and standardized procedures.
The response rate was 90%. The frequency of atopic dermatitis was calculated to be 15.6% (95% confidence interval 14.2% to 17%) with some regional differences. Girls more often had flexural eczema and outnumbered boys in a ratio of 1.3:1.0. Boys more often had a personal history of asthma, whereas girls more often had a family history of asthma.
The increasing prevalence of atopic dermatitis has been confirmed. This simple questionnaire model works well, is cost effective, and is sufficiently sensitive and specific to conduct large-scale epidemiologic investigations in school children.

0 Followers
 · 
131 Views
  • Source
    • "Atopic dermatitis affects 15 to 20% of preschool children in western countries [1] [2] [3] [4]. The lifetime prevalence of eczema in children aged 1–4 years in Värmland county, Sweden, was assessed in 2000 in the cohort study Dampness in Building and Health to be 22% [5]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Aim. To develop and validate a questionnaire for detecting atopic dermatitis in infants and small children from the age of 2 months. Methods. Parents to 60 children answered a written questionnaire prior to a physical examination and individual semistructured interview. Qualitative and quantitative analyses of validity, sensitivity, specificity, and predictive values of the questionnaire were performed. Results. A total of 27 girls and 33 boys, aged 2 to 71 months, 35 with and 25 without physician-diagnosed eczema, participated. Validation of the questionnaire by comparisons with physicians' diagnoses showed a sensitivity of 0.91 (95% CI 0.77-0.98) and a specificity of 1 (95% CI 0.86-1). Conclusions. Three questions in a parental questionnaire were sufficient for diagnosing eczema in infants and small children.
    Journal of Allergy 02/2012; 2012:945617. DOI:10.1155/2012/945617
  • Source
    • "Eczematous dermatitis is a chronic inflammatory skin disease, associated with cutaneous hyperreactivity, which usually occurs in individuals with an allergic background (also referred to as atopic dermatitis [AD]). One of its most striking features is the rising incidence during the past two decades, currently approaching 15%–30% of children at some point during childhood (Bieber, 2008; Schultz Larsen et al., 1996). Both genetic and environmental factors contribute to the development of AD (Bieber, 2008; Leung et al., 2007), but the underlying mechanisms by which such factors contribute to the pathogenesis of dermatitis are poorly defined. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The incidence of chronic allergic dermatitis is rapidly increasing. Regulatory control of this disease has not been adequately explored. Here we report that mast cell-derived interleukin-2 (IL-2) contributes to the suppression of chronic allergic dermatitis. Mice deficient in IL-2 production, or deficient in mast cells (Kit(W-sh/W-sh)), showed exacerbated dermatitis upon repeated oxazolone challenge when compared to their wild-type counterparts. Adoptive transfer of wild-type, but not Il2(-/-), mast cells into Kit(W-sh/W-sh) mice dampened the inflammatory response. During the course of disease, mast cell expansion occurred at the site of inflammation and also in the spleen, where production of IL-2 by mast cells was markedly enhanced. In the absence of mast cell IL-2 production, the ratio of activated to regulatory T cells at the site of inflammation was increased. Thus, MC-derived IL-2 contributes to the maintenance of suppression in chronic allergic skin inflammation.
    Immunity 10/2011; 35(4):562-71. DOI:10.1016/j.immuni.2011.07.013 · 19.75 Impact Factor
  • Source
    • "Environmental factors and psychosocial stress have been implicated in its exacerbation [1] [3] [4]. It has been estimated that patients with AD account for 30% of dermatology consultations in primary care and up to 20% of all referrals to dermatologists [1]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The aim of the study was to assess the influence of general and dermatitis-specific psychological and clinical factors on quality of life in adults with atopic dermatitis (AD). A total of 125 adults recruited through the National Eczema Society of U.K. (NES) completed a number of psychological and dermatological questionnaires, including the Dermatology Life Quality Index (DLQI), the Stigmatisation and Eczema Questionnaire (SEQ), the Hospital Anxiety and Depression Scale (HADS), the Fear of Negative Evaluation Scale (FNE) and the Rosenberg Self-Esteem Scale (RSE). Pearson's correlational analyses suggested that perceptions of stigma were significantly associated with psychological factors as well as quality of life (Ps<.01). An association was also found between perceived stigma and disease severity (-.28, P<.01). Almost 46% of participants were identified as having probable mood disorder. Regression analysis indicated that perceptions of stigma and depression accounted for 44.5% of the variance in quality of life in this sample [F(3,121)=34.18, P<.001], when disease severity was controlled for. Psychological factors and disease severity were strong predictors of quality of life in adults with AD. AD-related perceptions of stigma were of particular importance in predicting AD-related quality of life over and above more general psychological factors, such as depression. These findings have important implications for the psychological and clinical management of AD.
    Journal of Psychosomatic Research 08/2004; 57(2):195-200. DOI:10.1016/S0022-3999(03)00572-5 · 2.84 Impact Factor
Show more